224 related articles for article (PubMed ID: 27273569)
1. Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.
Nucifora FC; Nucifora LG; Ng CH; Arbez N; Guo Y; Roby E; Shani V; Engelender S; Wei D; Wang XF; Li T; Moore DJ; Pletnikova O; Troncoso JC; Sawa A; Dawson TM; Smith W; Lim KL; Ross CA
Nat Commun; 2016 Jun; 7():11792. PubMed ID: 27273569
[TBL] [Abstract][Full Text] [Related]
2. GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusions.
Thomas JM; Wang X; Guo G; Li T; Dai B; Nucifora LG; Nucifora FC; Liu Z; Xue F; Liu C; Ross CA; Smith WW
J Cell Physiol; 2020 Oct; 235(10):7309-7320. PubMed ID: 32180220
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
4. TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains.
Zucchelli S; Codrich M; Marcuzzi F; Pinto M; Vilotti S; Biagioli M; Ferrer I; Gustincich S
Hum Mol Genet; 2010 Oct; 19(19):3759-70. PubMed ID: 20634198
[TBL] [Abstract][Full Text] [Related]
5. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.
Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R
Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128
[TBL] [Abstract][Full Text] [Related]
6. WSB1: from homeostasis to hypoxia.
Haque M; Kendal JK; MacIsaac RM; Demetrick DJ
J Biomed Sci; 2016 Aug; 23(1):61. PubMed ID: 27542736
[TBL] [Abstract][Full Text] [Related]
7. Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease models.
Liu J; Li T; Thomas JM; Pei Z; Jiang H; Engelender S; Ross CA; Smith WW
Hum Mol Genet; 2016 Feb; 25(4):672-80. PubMed ID: 26744328
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons.
Henderson MX; Peng C; Trojanowski JQ; Lee VMY
Acta Neuropathol Commun; 2018 May; 6(1):45. PubMed ID: 29855356
[TBL] [Abstract][Full Text] [Related]
9. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
Smith WW; Pei Z; Jiang H; Moore DJ; Liang Y; West AB; Dawson VL; Dawson TM; Ross CA
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18676-81. PubMed ID: 16352719
[TBL] [Abstract][Full Text] [Related]
10. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).
Linhart R; Wong SA; Cao J; Tran M; Huynh A; Ardrey C; Park JM; Hsu C; Taha S; Peterson R; Shea S; Kurian J; Venderova K
Mol Neurodegener; 2014 Jun; 9():23. PubMed ID: 24915984
[TBL] [Abstract][Full Text] [Related]
11. Identification of Targets from LRRK2 Rescue Phenotypes.
Toh J; Chua LL; Ho P; Sandanaraj E; Tang C; Wang H; Tan EK
Cells; 2021 Jan; 10(1):. PubMed ID: 33466414
[TBL] [Abstract][Full Text] [Related]
12. A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.
Dusonchet J; Li H; Guillily M; Liu M; Stafa K; Derada Troletti C; Boon JY; Saha S; Glauser L; Mamais A; Citro A; Youmans KL; Liu L; Schneider BL; Aebischer P; Yue Z; Bandopadhyay R; Glicksman MA; Moore DJ; Collins JJ; Wolozin B
Hum Mol Genet; 2014 Sep; 23(18):4887-905. PubMed ID: 24794857
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
14. Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.
Mamais A; Raja M; Manzoni C; Dihanich S; Lees A; Moore D; Lewis PA; Bandopadhyay R
Neurobiol Dis; 2013 Oct; 58():183-90. PubMed ID: 23747310
[TBL] [Abstract][Full Text] [Related]
15. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32.
Gonzalez-Cano L; Menzl I; Tisserand J; Nicklas S; Schwamborn JC
Mol Neurobiol; 2018 Apr; 55(4):3490-3498. PubMed ID: 28508149
[TBL] [Abstract][Full Text] [Related]
17. G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.
Volpicelli-Daley LA; Abdelmotilib H; Liu Z; Stoyka L; Daher JP; Milnerwood AJ; Unni VK; Hirst WD; Yue Z; Zhao HT; Fraser K; Kennedy RE; West AB
J Neurosci; 2016 Jul; 36(28):7415-27. PubMed ID: 27413152
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons.
Bieri G; Brahic M; Bousset L; Couthouis J; Kramer NJ; Ma R; Nakayama L; Monbureau M; Defensor E; Schüle B; Shamloo M; Melki R; Gitler AD
Acta Neuropathol; 2019 Jun; 137(6):961-980. PubMed ID: 30927072
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
[TBL] [Abstract][Full Text] [Related]
20. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.
Ko HS; Bailey R; Smith WW; Liu Z; Shin JH; Lee YI; Zhang YJ; Jiang H; Ross CA; Moore DJ; Patterson C; Petrucelli L; Dawson TM; Dawson VL
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2897-902. PubMed ID: 19196961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
